Join to view full profile
75 Francis StAmory Lab Building, Pathology, 3rd FloorBoston, MA 02115
Phone+1 617-732-8613
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. John Hanna, MD is a board certified pathologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Dermatopathology, 2012 - 2013- Mass General Brigham/Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 2009 - 2013
Harvard Medical SchoolClass of 2009
Certifications & Licensure
MA State Medical License 2012 - 2026
American Board of Pathology Pathology - Anatomic- American Board of Pathology Dermatopathology
Publications & Presentations
PubMed
- 12 citationsD-SPIN constructs gene regulatory network models from multiplexed scRNA-seq data revealing organizing principles of cellular perturbation response.Jialong Jiang, Sisi Chen, Tiffany Tsou, Christopher S McGinnis, Tahmineh Khazaei
Biorxiv. 2025-05-23 - 1 citationsBRAF Gene Fusions in Melanoma: First Kinase Domain Duplication, New Fusion Partners, and Clinical Outcomes.Igor Odintsov, Dale Davis, Daniel Pissaloux, Franck Tirode, Arnaud de la Fouchardiere
The American Journal of Surgical Pathology. 2025-05-01 - 2 citationsClinicopathologic and Molecular Characterization of Basal Cell Carcinoma Arising at Sun-protected Sites.Elizabeth Draper, Yvonne Y Li, Navin R Mahadevan, Alvaro C Laga, John Hanna
The American Journal of Surgical Pathology. 2025-04-01
Press Mentions
No Cancer Left BehindApril 6th, 2021
Clear Cell Tumor with Melanocytic Differentiation and MITF-CREM Translocation: A Novel Entity Similar to Clear Cell SarcomaJanuary 18th, 2021
Grant Support
- Structural and Functional Analysis of Proteasome Core Particle BiogenesisBRIGHAM AND WOMEN'S HOSPITAL2022–2026
- Role of very long chain fatty acids in protein quality control and membrane homeostasisBRIGHAM AND WOMEN'S HOSPITAL2020–2025
